tiprankstipranks
Instil Bio (TIL)
NASDAQ:TIL
US Market

Instil Bio (TIL) Income Statement

Compare
133 Followers

Instil Bio Income Statement

Last quarter (Q3 2024), Instil Bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Instil Bio's net income was $-23.02M. See Instil Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 138.00K$ 0.00
Gross Profit
$ -4.76M$ -5.99M$ -2.75M$ 138.00K$ -20.00K
Operating Expenses
$ 85.78M$ 203.29M$ 155.56M$ 33.78M$ 6.58M
Depreciation and Amortization
$ 4.76M$ 5.99M$ 2.75M$ 256.00K$ 20.00K
EBITDA
$ -146.12M$ -217.38M$ -154.00M$ -33.39M$ -6.50M
Operating Income
$ -90.54M$ -226.46M$ -155.56M$ -33.64M$ -6.58M
Other Income/Expenses
$ -65.55M$ 1.21M$ -1.20M$ -3.94M$ 63.00K
Pretax Income
$ -156.09M$ -225.25M$ -156.75M$ -37.59M$ -6.52M
Net Income
$ -156.09M$ -223.18M$ -156.79M$ -37.74M$ -6.45M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -24.00$ -34.46$ -24.30$ -5.89$ -1.01
Diluted EPS
$ -24.00$ -34.46$ -24.30$ -5.89$ -1.01
Weighted Average Shares Outstanding
6.50M 6.48M 6.45M 6.41M 6.41M
Weighted Average Shares Outstanding (Diluted)
6.50M 6.48M 6.45M 6.41M 6.41M
Currency in USD

Instil Bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis